Journal Article

Impact of antimicrobial stewardship on antibiogram, consumption and incidence of multi drug resistance

Snaineh, Ahmad Atef Abu, Yahia, Ahmad Bassam, Darwish, Rula M., Matar, Sajeda Ghassan, Mustafa, Haneen Nidal, Hasabo, Elfatih A., Alsharif, Mohammad Refat

2022

Overview

Introduction Antimicrobial stewardship programs are intended to improve patient outcomes, reduce side effects, bacterial resistance, and costs. Thus, it is important to assess their impact on an ongoing basis. We aimed to assess the impact of the antimicrobial stewardship program in two different hospitals which used different program approaches. Methodology This is a retrospective observational study in two private hospitals [4088 patient records] in Amman- Jordan. Antibiotic susceptibility using antibiogram results, consumption of antibiotics using Defined Daily Dose, and the incidence of Multi-Drug Resistance were recorded using patients’ records during 2018, 2019, and 2020. Results Antimicrobial stewardship program outcomes varied between the two hospitals. Bacterial susceptibility to antibiotics were improved in both hospitals. Moreover, the defined daily dose in Hospital “A” showed no significant change in Fluoroquinolones, Carbapenems, and Piperacillin- Tazobactam, Cephalosporins, and Colistin, while a significant change was observed among Anti-MRSA antibiotics. Finally, the incidence of Extended Spectrum Beta-lactamase [ESBL] E. coli , ESBL Klebsiella , and Vancomycin Resistant Enterococci [VRE] have decreased numerically over the study period, while Methicillin-Resistant Staphylococcus aureus [MRSA] showed an increase in incidence during the second year of the study. Conclusion The study emphasizes the positive impact of the AMS program throughout the three years of the study. Plus, the need to enhance the program through recruiting extra staff and applying extra regulations like implementing educational programs for the hospital staff, designing local guidelines for common ID diseases, and monitoring the program’s outcomes which would eventually be more efficient, cost-effective, and safe.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Analysis / Antibiotic resistance / Antibiotics / Antiinfectives and antibacterials / Antimicrobial agents / Antimicrobial Stewardship / Antimicrobial stewardship program / Bacteria / Carbapenems / Cephalosporins / Colistin / Consumption / Disease control / Drug resistance / Drug resistance in microorganisms / Drug Resistance, Multiple / E coli / ESBL E. coli / ESBL Klebsiella / Escherichia coli / Fluoroquinolones / Hospitals / Humans / In vitro fertilization / Infections / Infectious Diseases / Intensive care / Internal Medicine / Jordan - epidemiology / Klebsiella / Laboratories / Medical Microbiology / Medicine / Medicine & Public Health / Methicillin / Methicillin-Resistant Staphylococcus aureus / Multi-drug resistance / Multidrug resistance / Multidrug resistant organisms / Observational studies / Parasitology / Patients / Pharmacists / Piperacillin / Pneumonia / Public health / Side effects / Staphylococcus aureus / Surgery / Tazobactam / Transplants & implants / Tropical Medicine / Vancomycin / β Lactamase